| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |